Congress Park Capital LLC Moderna, Inc. Transaction History

Congress Park Capital LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 13, 2023	BUY	$96.41 - $126.61 $158,112 - $207,640	1,640 Added 35.65%	6,240 $644,000
Q2 2023 Jul 13, 2023	BUY	$118.5 - $160.53 $148,125 - $200,662	1,250 Added 37.31%	4,600 $558,000
Q1 2023 Apr 19, 2023	BUY	$135.66 - $197.02 $26,453 - $38,418	195 Added 6.18%	3,350 $514,000
Q4 2022 Jan 27, 2023	SELL	$118.38 - $210.04 $112,461 - $199,538	-950 Reduced 23.14%	3,155 $566,000
Q3 2022 Oct 18, 2022	BUY	$118.07 - $194.18 $88,552 - $145,635	750 Added 22.35%	4,105 $485,000
Q2 2022 Jul 22, 2022	BUY	$117.13 - $176.59 $120,058 - $181,004	1,025 Added 43.99%	3,355 $479,000
Q1 2022 May 02, 2022	BUY	$126.46 - $235.05 $152,890 - $284,175	1,209 Added 107.85%	2,330 $401,000
Q4 2021 Feb 09, 2022	BUY	$225.82 - $368.51 $253,144 - $413,099	1,121 New	1,121 $285,000
Q2 2021 Aug 13, 2021	SELL	$129.91 - $234.98 $313,342 - $566,771	-2,412 Closed	0 $0
Q1 2021 Apr 19, 2021	BUY	$109.18 - $185.98 $263,342 - $448,583	2,412 New	2,412 $316,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Congress Park Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Congress Park Capital LLC with notifications on news.